Clinical Trial Update: Palliative UNConventional Hypofractionation Trial for Metastatic Bone Disease [Phase 3]

View source ↗

Summary

Phase 3 trial update on palliative ultraconventional hypofractionation for metastatic bone disease; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastasis

Snippet

Sponsor: University of Cincinnati | Conditions: Metastatic Bone Tumor | Phase 3 | Status: ACTIVE_NOT_RECRUITING